Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report No. 14

Archives of Ophthalmology

Volumn 123, Issue 9, 2005, Pages 1207-1214

  Lindblad, Anne S ^a   Clemons, Traci E ^a  

^a EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COLOR VISION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LENS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; SOCIAL ASPECT; STATISTICAL ANALYSIS; VISION; VISUAL ACUITY; CATARACT; CLINICAL TRIAL; HEALTH CARE ORGANIZATION; MIDDLE AGED; MULTICENTER STUDY; OPHTHALMOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUALITY OF LIFE; RETINA MACULA DEGENERATION; SICKNESS IMPACT PROFILE; UNITED STATES; VISUAL DISORDER;

AGED; AGED, 80 AND OVER; CATARACT; DISEASE PROGRESSION; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); OPHTHALMOLOGY; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; UNITED STATES; VISION DISORDERS; VISUAL ACUITY;

EID: 24944502750     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.9.1207     Document Type: Article

References (23)

1. AREDS Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8. Arch Ophthalmol. 2001;119:1417-1436.
2. AREDS Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta-carotene for age-related cataract and vision loss: AREDS report No. 9. Arch Ophthalmol. 2001;119:1439-1452.
3. Mangione CM, Lee PP, Pitts J, Guiterrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116:1496-1504.
4. Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res. 1993;2:221-226.
5. Stratford PW, Binkley JM, Riddle DL. Health status measures: strategies and analytic methods for assessing change scores. Phys Ther. 1996;76:1109-1123.
6. Miskala PH, Hawkins BS, Mangione CM, et al; Submacular Surgery Trials Research Group. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization - SST report No. 1 (published correction appears in Arch Ophthalmol. 2003;121:1513). Arch Ophthalmol. 2003;121:531-539.
7. AREDS Research Group. The Age-Related Eye Disease Study (AREDS): design implications: AREDS report No. 1. Control Clin Trials. 1999;20:573-600.
8. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum. 1985;28:542-547.
9. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Orlando, Fla: Academic Press Inc: 1977.
10. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Orlando, Fla: Academic Press Inc: 1988.
11. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40:171-178.
12. Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978;8:283-298.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
14. Cassard SD, Patrick DL, Damiana AM, et al. Reproducibility and responsiveness of the VF-14: an index of functional impairment in patients with cataracts. Arch Ophthalmol. 1995;113:1508-1513.
15. AREDS Research Group. The National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS report No. 10. Arch Ophthalmol. 2003;121:211-217.
16. Shuttleworth GN, Luhishi EA, Harrad RA. Do patients with age related maculopathy and cataract benefit from cataract surgery? Br J Ophthalmol. 1998;82:611-616.
17. Margolis MK, Coyne K, Kennedy-Martin T, Baker T, Schein O, Revicki DA. Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review. Pharmacoeconomics. 2002;20:791-812.
18. Boisjoly H, Gresset J, Charest M, et al. The VF-14 index of visual function in recipients of a corneal graft: a 2-year follow-up study. Am J Ophthalmol. 2002;134:166-171.
19. Stelmack JA, Stelmack TR, Massof RW. Measuring low vision rehabilitation outcomes with the NEI VFQ-25. Invest Ophthalmol Vis Sci. 2002;43:2859-2868.
20. Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology. 2002;109:1235-1242.
21. Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of age-related maculopathy on visual functioning and health related quality of life. Am J Ophthalmol. 1999;128:45-52.
22. Mackenzie PJ, Chang TS, Scott IU, et al. Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology. 2002;109:720-729.
23. Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol. 2002;120:1041-1044.